Immunological, Clinical, and Epidemiological Features of Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection

<div>The proportion of patients with GBS with facial paralysis (a) and anti-SSA/Ro60 antibodies (b) according to SARS-CoV-2-related event. FP: facial paralysis; GBS: Guillain-Barré syndrome; O: other antecedent infection; S: SARS-CoV-2 infection; V: SARS-CoV-2 vaccination.</div>

Acta Neurologica Scandinavica

fig2

Figure 2

Figure 2: Immunological, Clinical, and Epidemiological Features of Guillain-Barré Syndrome Associated with SARS-CoV-2 Infection 